Description
AQYNZIO® 0
indicado para el tratamiento de cáncer de pulmón de células no pequeñas (CPCNP) con mutaciones específicas del EGFR
Tratamiento de cáncer de próstata metastásico en combinación con terapia de deprivación androgénica (ADT)
DOSIS: 120/200 MG
ALEGORIA 0 05%SUSP PED10ML 60D LAMINARIA SACCHARINA EXTRACT/ALGAE EXTRACT AQYNZIO® 010 ML Suspensin Atomizador Furoato de mometasona 0. 05 G
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
